Effects of gallinacin-13 on growth and disease resistance in Tilapia nilotica

Peng KaiSong,She RuiPing,Yang YuRong,Wang DeCheng,Hu YanXin

2009-01-01

Abstract:To evaluate the feasibility of the gallinacin-13(Gal-13)as substitutes for antibiotics in fish,150 uniform Tilapia nilotica from the same pond were assigned randomly to two groups.The tilapias in control group were fed with a commercial tilapia diet,and the tilapias in experimental group were fed with the same commercial diet supplemented with Gal-13 at 100 mg/kg.After T.nilotica were fed for 21 days,growth,disease resistance,and in vivo anti-adherence were determined by weight gain(%),relative percent survival and scanning electron microscope respectively.Furthermore,the inhibitory effect of Gal-13 on adhesion of Aeromonas veronii biovar.sobria(A.vbs)strain BJCP-9 to tilapia enteric epithelia in vitro was assessed by cell-ELISA system.The Gal-13 supplemented at 100 mg/kg showed significant benefit to tilapia's growth and its disease resistance(P0.05),and the benefit may be correlated with their interfering in the contact of bacteria with host mucosal surface.Although the tested agent did not inhibit the growth of BJCP-9 in tryptic soy broth at 100 μg/mL,Gal-13 did inhibit the adhesion of A.vbs to tilapia enteric epithelia in vivo and in vitro.In vitro mimic assays showed that Gal-13 at low concentrations of 25 μg/mL and 2.5 μg/mL had the reciprocal dose-dependent anti-adherence effect.The results indicated that the anti-adherence of the Gal-13 may be one of the mechanisms in promoting tilapia's growth and disease resistance to A.vbs,and the inhibition of Gal-13 may be correlated with a cation bridging and/or receptor-ligand binding,but not with hydrophobicity.